. . "978-80-247-5048-4" . "Biologick\u00E1 l\u00E9\u010Dba z\u00E1n\u011Btliv\u00FDch autoimunitn\u00EDch onemocn\u011Bn\u00ED: v revmatologii, gastroenterologii a dermatologii" . "Kniha je prvn\u00ED interdisciplin\u00E1rn\u00ED monografi\u00ED v \u010Cesk\u00E9 republice, kter\u00E1 se komplexn\u011B zab\u00FDv\u00E1 problematikou biologick\u00FDch l\u00E9k\u016F. Ve sv\u00E9 prvn\u00ED \u010D\u00E1sti obsahuje teoretick\u00E9 p\u0159edpoklady produkce biologick\u00FDch l\u00E9k\u016F a technick\u00E9 probl\u00E9my t\u00FDkaj\u00EDc\u00ED se jej\u00ED v\u00FDroby, zkou\u0161en\u00ED a zav\u00E1d\u011Bn\u00ED do praxe. Kniha je roz\u010Dlen\u011Bna do t\u0159\u00ED relativn\u011B samostatn\u00FDch \u010D\u00E1st\u00ED t\u00FDkaj\u00EDc\u00EDch se revmatologie, gastroenterologie a dermatologie. V ka\u017Ed\u00E9 \u010D\u00E1sti je jednak l\u00E9kov\u00FD profil jednotliv\u00FDch l\u00E9k\u016F obsahuj\u00EDc\u00ED jejich mechanizmus \u00FA\u010Dinku, klinick\u00E9 zku\u0161enosti o \u00FA\u010Dinnosti a bezpe\u010Dnosti a dlouhodob\u00E1 data. D\u00E1le pak obsahuje u definovan\u00FDch onemocn\u011Bn\u00ED v\u017Edy strategii l\u00E9\u010Dby a postaven\u00ED t\u011Bchto l\u00E9k\u016F v algoritmu l\u00E9\u010Dby jednotliv\u00FDch diagn\u00F3z. Zvl\u00E1\u0161tn\u00ED kapitola je v\u011Bnov\u00E1na problematice biosimil\u00E1rn\u00EDch l\u00E9k\u016F, kter\u00E9 v sou\u010Dasn\u00E9 dob\u011B vstupuj\u00ED na trh. Jedna kapitola pojedn\u00E1v\u00E1 tak\u00E9 o v\u00FDvoji biologick\u00FDch l\u00E9k\u016F, respektive o nov\u00FDch molekul\u00E1ch, kter\u00E9 jsou v procesu klinick\u00E9ho zkou\u0161en\u00ED a p\u0159ibli\u017Euj\u00ED se k registraci. Zcela samostatn\u00E9 kapitoly jsou pak o biologick\u00E9 l\u00E9\u010Db\u011B syst\u00E9mov\u00E9ho lupus erytematodes a biologick\u00E9 l\u00E9\u010Db\u011B osteopor\u00F3zy, kde byly ned\u00E1vno registrov\u00E1ny prvn\u00ED prepar\u00E1ty. Biologick\u00E1 l\u00E9\u010Dba je velmi \u00FA\u010Dinn\u00E1, ale drah\u00E1 a proto tak\u00E9 byla za\u0159azena kapitola o farmakoekonomice biologick\u00FDch l\u00E9k\u016F, kter\u00E1 vyhodnocuje mezin\u00E1rodn\u011B uzn\u00E1van\u00E9 ukazatele v\u00FDhodnosti farmakoekonomick\u00E9 l\u00E9\u010Dby u jednotliv\u00FDch diagn\u00F3z a vytipov\u00E1v\u00E1 nejvhodn\u011Bj\u0161\u00ED pacienty pro indikaci biologick\u00E9 l\u00E9\u010Dby."@cs . . . . "11120" . "Praha" . "1"^^ . "Biologick\u00E1 l\u00E9\u010Dba z\u00E1n\u011Btliv\u00FDch autoimunitn\u00EDch onemocn\u011Bn\u00ED: v revmatologii, gastroenterologii a dermatologii"@cs . "[0F3C6718F561]" . "Biologick\u00E1 l\u00E9\u010Dba z\u00E1n\u011Btliv\u00FDch autoimunitn\u00EDch onemocn\u011Bn\u00ED: v revmatologii, gastroenterologii a dermatologii" . "Biologick\u00E1 l\u00E9\u010Dba z\u00E1n\u011Btliv\u00FDch autoimunitn\u00EDch onemocn\u011Bn\u00ED: v revmatologii, gastroenterologii a dermatologii" . "5402" . "388"^^ . "Biologick\u00E1 l\u00E9\u010Dba z\u00E1n\u011Btliv\u00FDch autoimunitn\u00EDch onemocn\u011Bn\u00ED: v revmatologii, gastroenterologii a dermatologii"@cs . . . . . "Biological treatment of inflammatory autoimmune diseases: in rheumatology, gastroenterology and dermatology"@en . "388"^^ . "Kniha je prvn\u00ED interdisciplin\u00E1rn\u00ED monografi\u00ED v \u010Cesk\u00E9 republice, kter\u00E1 se komplexn\u011B zab\u00FDv\u00E1 problematikou biologick\u00FDch l\u00E9k\u016F. Ve sv\u00E9 prvn\u00ED \u010D\u00E1sti obsahuje teoretick\u00E9 p\u0159edpoklady produkce biologick\u00FDch l\u00E9k\u016F a technick\u00E9 probl\u00E9my t\u00FDkaj\u00EDc\u00ED se jej\u00ED v\u00FDroby, zkou\u0161en\u00ED a zav\u00E1d\u011Bn\u00ED do praxe. Kniha je roz\u010Dlen\u011Bna do t\u0159\u00ED relativn\u011B samostatn\u00FDch \u010D\u00E1st\u00ED t\u00FDkaj\u00EDc\u00EDch se revmatologie, gastroenterologie a dermatologie. V ka\u017Ed\u00E9 \u010D\u00E1sti je jednak l\u00E9kov\u00FD profil jednotliv\u00FDch l\u00E9k\u016F obsahuj\u00EDc\u00ED jejich mechanizmus \u00FA\u010Dinku, klinick\u00E9 zku\u0161enosti o \u00FA\u010Dinnosti a bezpe\u010Dnosti a dlouhodob\u00E1 data. D\u00E1le pak obsahuje u definovan\u00FDch onemocn\u011Bn\u00ED v\u017Edy strategii l\u00E9\u010Dby a postaven\u00ED t\u011Bchto l\u00E9k\u016F v algoritmu l\u00E9\u010Dby jednotliv\u00FDch diagn\u00F3z. Zvl\u00E1\u0161tn\u00ED kapitola je v\u011Bnov\u00E1na problematice biosimil\u00E1rn\u00EDch l\u00E9k\u016F, kter\u00E9 v sou\u010Dasn\u00E9 dob\u011B vstupuj\u00ED na trh. Jedna kapitola pojedn\u00E1v\u00E1 tak\u00E9 o v\u00FDvoji biologick\u00FDch l\u00E9k\u016F, respektive o nov\u00FDch molekul\u00E1ch, kter\u00E9 jsou v procesu klinick\u00E9ho zkou\u0161en\u00ED a p\u0159ibli\u017Euj\u00ED se k registraci. Zcela samostatn\u00E9 kapitoly jsou pak o biologick\u00E9 l\u00E9\u010Db\u011B syst\u00E9mov\u00E9ho lupus erytematodes a biologick\u00E9 l\u00E9\u010Db\u011B osteopor\u00F3zy, kde byly ned\u00E1vno registrov\u00E1ny prvn\u00ED prepar\u00E1ty. Biologick\u00E1 l\u00E9\u010Dba je velmi \u00FA\u010Dinn\u00E1, ale drah\u00E1 a proto tak\u00E9 byla za\u0159azena kapitola o farmakoekonomice biologick\u00FDch l\u00E9k\u016F, kter\u00E1 vyhodnocuje mezin\u00E1rodn\u011B uzn\u00E1van\u00E9 ukazatele v\u00FDhodnosti farmakoekonomick\u00E9 l\u00E9\u010Dby u jednotliv\u00FDch diagn\u00F3z a vytipov\u00E1v\u00E1 nejvhodn\u011Bj\u0161\u00ED pacienty pro indikaci biologick\u00E9 l\u00E9\u010Dby." . "RIV/00216208:11120/14:43909116!RIV15-MSM-11120___" . . "The book is the first interdisciplinary monographs in the Czech Republic, which deals comprehensively with the issue of biological agents. The first part contains theoretical assumptions production of biological agents and technical problems relating to the manufacture, testing and implementation. The book is divided into three relatively independent parts related to rheumatology, gastroenterology and dermatology. In each part is both medication profiles of drugs containing their mechanism of action, clinical experience on the efficacy and safety of a long-term data. It also includes u always defined disease treatment strategy and the status of these drugs in the treatment algorithm individual diagnoses. A special chapter is devoted to the biosimil\u00E1rn\u00EDch drugs that are currently entering the market. One chapter also discusses the development of biological drugs, respectively new molecules that are in the process of clinical testing and closer to registration. Completely separate chapters are on Biological treatment of systemic lupus erythematosus and biological treatment of osteoporosis, which were recently registered the first medication. Biological treatment is very effective but expensive and therefore also include a chapter on farmakoekonomice biological drugs, which evaluates internationally recognized indicators pharmacoeconomic benefits of treatment for individual diagnoses and single out the most appropriate patients for the indication of biological therapy."@en . "23"^^ . "Arenberger, Petr" . "Grada Publ." . "dermatology; gastroenterology; rheumatology; autoimmune diseases; Biological treatment"@en . . . "RIV/00216208:11120/14:43909116" . . "Biological treatment of inflammatory autoimmune diseases: in rheumatology, gastroenterology and dermatology"@en . . "I, V" . . . .